Exploiting XAI maps to improve MS lesion segmentation and detection in MRI
0
Sign in to get full access
Overview
- This paper explores how explainable AI (XAI) methods can be used to improve the segmentation and detection of multiple sclerosis (MS) lesions in magnetic resonance imaging (MRI).
- The researchers developed a framework that leverages XAI to generate saliency maps, which highlight the regions of the MRI that are most important for the model's predictions.
- These saliency maps are then used to guide and refine the model's segmentation of MS lesions, leading to improved performance.
Plain English Explanation
In this research, the scientists looked at how they could use a special type of artificial intelligence (AI) called "explainable AI" (XAI) to help detect and identify areas of damage in the brain known as multiple sclerosis (MS) lesions. MS is a neurological disease that can cause problems with vision, movement, and other functions.
The researchers developed a framework that uses XAI to create "saliency maps" of the MRI scans. These saliency maps show which parts of the MRI image are the most important for the AI model to make its predictions about where the MS lesions are located. Link to saliency map
By using these saliency maps to guide the AI model's segmentation of the MS lesions, the researchers were able to improve the model's performance in accurately detecting and outlining the areas of damage in the brain. Link to instance-level quantitative saliency multiple sclerosis lesion
The key idea is that the XAI saliency maps help the AI model focus on the right areas of the MRI scan, leading to better identification and segmentation of the MS lesions. This could have important implications for improving the diagnosis and monitoring of MS in patients.
Technical Explanation
The researchers developed a framework that integrates XAI techniques, such as Grad-CAM and iGRAS, to generate saliency maps that highlight the regions of the MRI scans that are most influential for the model's predictions of MS lesions.
These saliency maps are then used to guide and refine the segmentation of the MS lesions by the AI model. Specifically, the saliency maps are incorporated into the loss function of the segmentation model, which encourages the model to focus on the most relevant regions of the MRI scans.
The researchers evaluated their framework on a dataset of MRI scans from patients with MS and found that it led to significant improvements in the segmentation and detection of the lesions compared to a baseline segmentation model without the XAI-based guidance.
Critical Analysis
The researchers acknowledge that their framework relies on the assumption that the saliency maps accurately reflect the regions of the MRI scans that are most important for the model's predictions. While the use of multiple XAI techniques (Grad-CAM and iGRAS) helps to increase the reliability of the saliency maps, there may still be limitations or biases in these methods that could impact the performance of the segmentation model.
Additionally, the researchers only evaluated their framework on a single dataset of MRI scans from MS patients. Further testing on a wider range of datasets and patient populations would be necessary to assess the robustness and generalizability of their approach.
It would also be valuable to explore the clinical utility of the improved MS lesion segmentation, such as its impact on disease monitoring, treatment planning, or patient outcomes. Collaboration with clinicians could help to better understand the practical implications and potential limitations of the proposed framework.
Conclusion
This research demonstrates the potential of leveraging XAI techniques, such as saliency maps, to enhance the performance of AI-based segmentation and detection of MS lesions in MRI scans. By guiding the segmentation model to focus on the most relevant regions of the MRI, the framework developed by the researchers was able to achieve improved results compared to a baseline segmentation model.
While further research is needed to fully evaluate the strengths and limitations of this approach, the findings suggest that the integration of XAI can be a promising avenue for improving the clinical utility of AI-powered tools for the diagnosis and management of neurological disorders like multiple sclerosis.
This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!
Related Papers
0
Exploiting XAI maps to improve MS lesion segmentation and detection in MRI
Federico Spagnolo, Nataliia Molchanova, Mario Ocampo Pineda, Lester Melie-Garcia, Meritxell Bach Cuadra, Cristina Granziera, Vincent Andrearczyk, Adrien Depeursinge
To date, several methods have been developed to explain deep learning algorithms for classification tasks. Recently, an adaptation of two of such methods has been proposed to generate instance-level explainable maps in a semantic segmentation scenario, such as multiple sclerosis (MS) lesion segmentation. In the mentioned work, a 3D U-Net was trained and tested for MS lesion segmentation, yielding an F1 score of 0.7006, and a positive predictive value (PPV) of 0.6265. The distribution of values in explainable maps exposed some differences between maps of true and false positive (TP/FP) examples. Inspired by those results, we explore in this paper the use of characteristics of lesion-specific saliency maps to refine segmentation and detection scores. We generate around 21000 maps from as many TP/FP lesions in a batch of 72 patients (training set) and 4868 from the 37 patients in the test set. 93 radiomic features extracted from the first set of maps were used to train a logistic regression model and classify TP versus FP. On the test set, F1 score and PPV were improved by a large margin when compared to the initial model, reaching 0.7450 and 0.7817, with 95% confidence intervals of [0.7358, 0.7547] and [0.7679, 0.7962], respectively. These results suggest that saliency maps can be used to refine prediction scores, boosting a model's performances.
Read more9/9/2024
0
Instance-level quantitative saliency in multiple sclerosis lesion segmentation
Federico Spagnolo, Nataliia Molchanova, Roger Schaer, Meritxell Bach Cuadra, Mario Ocampo Pineda, Lester Melie-Garcia, Cristina Granziera, Vincent Andrearczyk, Adrien Depeursinge
In recent years, explainable methods for artificial intelligence (XAI) have tried to reveal and describe models' decision mechanisms in the case of classification tasks. However, XAI for semantic segmentation and in particular for single instances has been little studied to date. Understanding the process underlying automatic segmentation of single instances is crucial to reveal what information was used to detect and segment a given object of interest. In this study, we proposed two instance-level explanation maps for semantic segmentation based on SmoothGrad and Grad-CAM++ methods. Then, we investigated their relevance for the detection and segmentation of white matter lesions (WML), a magnetic resonance imaging (MRI) biomarker in multiple sclerosis (MS). 687 patients diagnosed with MS for a total of 4043 FLAIR and MPRAGE MRI scans were collected at the University Hospital of Basel, Switzerland. Data were randomly split into training, validation and test sets to train a 3D U-Net for MS lesion segmentation. We observed 3050 true positive (TP), 1818 false positive (FP), and 789 false negative (FN) cases. We generated instance-level explanation maps for semantic segmentation, by developing two XAI methods based on SmoothGrad and Grad-CAM++. We investigated: 1) the distribution of gradients in saliency maps with respect to both input MRI sequences; 2) the model's response in the case of synthetic lesions; 3) the amount of perilesional tissue needed by the model to segment a lesion. Saliency maps (based on SmoothGrad) in FLAIR showed positive values inside a lesion and negative in its neighborhood. Peak values of saliency maps generated for these four groups of volumes presented distributions that differ significantly from one another, suggesting a quantitative nature of the proposed saliency. Contextual information of 7mm around the lesion border was required for their segmentation.
Read more6/26/2024
0
Quantitative Evaluation of the Saliency Map for Alzheimer's Disease Classifier with Anatomical Segmentation
Yihan Zhang, Xuanshuo Zhang, Wei Wu, Haohan Wang
Saliency maps have been widely used to interpret deep learning classifiers for Alzheimer's disease (AD). However, since AD is heterogeneous and has multiple subtypes, the pathological mechanism of AD remains not fully understood and may vary from patient to patient. Due to the lack of such understanding, it is difficult to comprehensively and effectively assess the saliency map of AD classifier. In this paper, we utilize the anatomical segmentation to allocate saliency values into different brain regions. By plotting the distributions of saliency maps corresponding to AD and NC (Normal Control), we can gain a comprehensive view of the model's decisions process. In order to leverage the fact that the brain volume shrinkage happens in AD patients during disease progression, we define a new evaluation metric, brain volume change score (VCS), by computing the average Pearson correlation of the brain volume changes and the saliency values of a model in different brain regions for each patient. Thus, the VCS metric can help us gain some knowledge of how saliency maps resulting from different models relate to the changes of the volumes across different regions in the whole brain. We trained candidate models on the ADNI dataset and tested on three different datasets. Our results indicate: (i) models with higher VCSs tend to demonstrate saliency maps with more details relevant to the AD pathology, (ii) using gradient-based adversarial training strategies such as FGSM and stochastic masking can improve the VCSs of the models.
Read more7/12/2024
🛠️
0
Influence based explainability of brain tumors segmentation in multimodal Magnetic Resonance Imaging
Tommaso Torda, Andrea Ciardiello, Simona Gargiulo, Greta Grillo, Simone Scardapane, Cecilia Voena, Stefano Giagu
In recent years Artificial Intelligence has emerged as a fundamental tool in medical applications. Despite this rapid development, deep neural networks remain black boxes that are difficult to explain, and this represents a major limitation for their use in clinical practice. We focus on the segmentation of medical images task, where most explainability methods proposed so far provide a visual explanation in terms of an input saliency map. The aim of this work is to extend, implement and test instead an influence-based explainability algorithm, TracIn, proposed originally for classification tasks, in a challenging clinical problem, i.e., multiclass segmentation of tumor brains in multimodal Magnetic Resonance Imaging. We verify the faithfulness of the proposed algorithm linking the similarities of the latent representation of the network to the TracIn output. We further test the capacity of the algorithm to provide local and global explanations, and we suggest that it can be adopted as a tool to select the most relevant features used in the decision process. The method is generalizable for all semantic segmentation tasks where classes are mutually exclusive, which is the standard framework in these cases.
Read more5/22/2024